Birdwatch Note
2024-09-19 22:47:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
不活化ワクチンはそこまでリスクなくて、mRNAワクチンはすごい危険、等の動画の持論に関してですが実際は下記の通りです。 ファイザーワクチンと不活化ワクチンcoronavac(1)の接種後の特に注意する有害事象の医療記録を香港で直接比較した研究によると、死亡率は差がみられず、アナフィラキシーや睡眠障害、心筋炎は前者が多い一方、後者はベル麻痺が有意に多く、全体的な有害事象は有意差が見られずという結果でした(2,3)。 (1) https://medical.nikkeibp.co.jp/leaf/mem/pub/report/t344/202108/571415.html (2) https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018 (3) https://www.sciencedirect.com/science/article/pii/S1201971224002200 有効性に関しては同じく直接比較を行うとオミクロンに対してファイザーワクチンの方が大きく上回っています。 https://www.sciencedirect.com/science/article/pii/S1201971224002200
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1836881297505145173
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1836900069167206412
- noteId - 1836900069167206412
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1726786079098
- tweetId - 1836881297505145173
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 不活化ワクチンはそこまでリスクなくて、mRNAワクチンはすごい危険、等の動画の持論に関してですが実際は下記の通りです。 ファイザーワクチンと不活化ワクチンcoronavac(1)の接種後の特に注意する有害事象の医療記録を香港で直接比較した研究によると、死亡率は差がみられず、アナフィラキシーや睡眠障害、心筋炎は前者が多い一方、後者はベル麻痺が有意に多く、全体的な有害事象は有意差が見られずという結果でした(2,3)。 (1) https://medical.nikkeibp.co.jp/leaf/mem/pub/report/t344/202108/571415.html (2) https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018 (3) https://www.sciencedirect.com/science/article/pii/S1201971224002200 有効性に関しては同じく直接比較を行うとオミクロンに対してファイザーワクチンの方が大きく上回っています。 https://www.sciencedirect.com/science/article/pii/S1201971224002200
Note Ratings
rated at | rated by | |
2024-09-21 09:39:08 -0500 | Rating Details | |
2024-09-20 03:42:20 -0500 | Rating Details | |
2024-09-20 03:31:31 -0500 | Rating Details | |
2024-09-20 01:59:03 -0500 | Rating Details | |
2024-09-20 01:58:56 -0500 | Rating Details | |
2024-09-20 01:48:07 -0500 | Rating Details | |
2024-09-20 01:34:43 -0500 | Rating Details | |
2024-09-19 23:36:56 -0500 | Rating Details | |
2024-09-19 23:34:05 -0500 | Rating Details | |
2024-09-19 23:32:30 -0500 | Rating Details | |
2024-09-19 23:21:11 -0500 | Rating Details | |
2024-09-19 22:55:24 -0500 | Rating Details | |
2024-09-19 22:43:49 -0500 | Rating Details | |
2024-09-19 22:38:09 -0500 | Rating Details | |
2024-09-19 22:35:02 -0500 | Rating Details | |
2024-09-19 22:28:09 -0500 | Rating Details | |
2024-09-19 22:23:55 -0500 | Rating Details | |
2024-09-19 22:18:48 -0500 | Rating Details | |
2024-09-19 22:17:44 -0500 | Rating Details | |
2024-09-19 22:06:12 -0500 | Rating Details | |
2024-09-19 21:54:29 -0500 | Rating Details | |
2024-09-19 21:45:54 -0500 | Rating Details | |
2024-09-19 21:38:12 -0500 | Rating Details | |
2024-09-19 21:27:47 -0500 | Rating Details | |
2024-09-19 20:52:14 -0500 | Rating Details | |
2024-09-19 20:39:16 -0500 | Rating Details | |
2024-09-19 20:35:44 -0500 | Rating Details | |
2024-09-19 20:16:22 -0500 | Rating Details | |
2024-09-19 20:10:46 -0500 | Rating Details | |
2024-09-19 20:03:07 -0500 | Rating Details | |
2024-09-19 20:02:22 -0500 | Rating Details | |
2024-09-19 20:02:19 -0500 | Rating Details | |
2024-09-19 19:42:49 -0500 | Rating Details | |
2024-09-19 19:37:39 -0500 | Rating Details | |
2024-09-19 19:27:38 -0500 | Rating Details | |
2024-09-19 19:26:52 -0500 | Rating Details | |
2024-09-19 19:26:09 -0500 | Rating Details | |
2024-09-19 18:52:03 -0500 | Rating Details | |
2024-09-19 18:45:50 -0500 | Rating Details | |
2024-09-19 18:44:45 -0500 | Rating Details | |
2024-09-19 18:43:24 -0500 | Rating Details | |
2024-09-19 18:36:53 -0500 | Rating Details | |
2024-09-19 18:33:46 -0500 | Rating Details | |
2024-09-19 18:33:18 -0500 | Rating Details | |
2024-09-19 18:30:57 -0500 | Rating Details | |
2024-09-19 18:25:57 -0500 | Rating Details | |
2024-09-19 18:25:33 -0500 | Rating Details | |
2024-09-19 18:25:12 -0500 | Rating Details | |
2024-09-19 18:11:29 -0500 | Rating Details | |
2024-09-19 18:09:58 -0500 | Rating Details | |
2024-09-19 18:06:31 -0500 | Rating Details | |
2024-09-19 17:55:50 -0500 | Rating Details | |
2024-09-19 17:52:19 -0500 | Rating Details | |
2024-09-19 17:50:18 -0500 | Rating Details | |
2024-09-19 17:50:13 -0500 | Rating Details |